9 completed. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
Follow Latent Infection: new trials by email Literature Review of Latent Infection trials Research Report on Latent Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above Recombinant Mycobacterium Tuberculosis Fusion Protein, Purified Protein Derivative of Tuberculin - Latent Tuberculosis Infection | Phase 3 | Completed | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 780 | 2023-08-03 | 2026-04-30 |
| Alternative Antibiotics for Syphilis Linezolid 600 mg (post-interim), Benzathine Penicilllin G (post-interim) - Early Latent Syphilis, Primary Syphilis | Phase 3 | Completed | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 165 | 2021-10-14 | 2026-07-29 |
| Risk of SDRs Under 3HP and 1HP Regimen for LTBI isoniazid and rifapentine - Latent Tuberculosis Infection | Phase 3 | Completed | National Taiwan University Hospital | 490 | 2019-09-24 | 2023-12-26 |
| Trial of Vitamin D Supplementation in Cape Town Primary Schoolchildren Cholecalciferol, Placebo - Latent Tuberculosis | Phase 3 | Completed | Queen Mary University of London | 1743 | 2017-03-14 | 2022-09-08 |
| Vitamin D Supplementation in TB Prevention Cholecalciferol (vitamin D3), Placebo - Latent Tuberculosis | Phase 3 | Completed | Harvard School of Public Health (HSPH) | 8851 | 2015-09-01 | 2020-07-16 |
| Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT Self Administered Therapy (SAT), SMS reminders, isoniazid and rifapentine - Latent Tuberculosis Infection | Phase 3 | Completed | Centers for Disease Control and Prevention | 1002 | 2012-09-01 | 2025-03-13 |
| Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9) Isoniazid, Rifampin - Latent Tuberculosis Infection | Phase 3 | Completed | McGill University | 844 | 2011-08-01 | 2017-12-19 |
| Treatment of Mycobacterium Xenopi Pulmonary Infection Clarithromycin, Moxifloxacin - Atypical; Mycobacterium, Pulmonary, Tuberculous | Phase 3 | Completed | Centre Hospitalier Universitaire, Amiens | 92 | 2011-03-02 | 2025-11-19 |
| Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness Isoniazid, Rifampin - Latent Tuberculosis Infection | Phase 3 | Completed | McGill University | 6031 | 2009-08-01 | 2017-12-19 |
Latent Tuberculosis (8) · Tuberculosis (2) · Mycobacterium Infections (1) · Syphilis (1) · Syphilis, Latent (1) · Syphilis, primary (1) · Syphilis, secondary (1) · Treponemal Infections (1)
Bacterial Infections (9) · Bacterial Infections and Mycoses (9) · Infections (9) · Actinomycetales Infections (8) · Gram-Positive Bacterial Infections (8) · Mycobacterium Infections (7) · Tuberculosis (6) · Communicable Diseases (1) · Genital Diseases (1) · Gram-Negative Bacterial Infections (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Bacterial (1) · Spirochaetales Infections (1) · Urogenital Diseases (1)
Isoniazid (4) · Cholecalciferol (2) · Rifampin (2) · rifapentine (2) · Clarithromycin (1) · Linezolid (1) · Moxifloxacin (1) · Tuberculin (1)
McGill University (2) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (1) · Centers for Disease Control and Prevention (1) · Centre Hospitalier Universitaire, Amiens (1) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1) · Harvard School of Public Health (HSPH) (1) · National Taiwan University Hospital (1) · Queen Mary University of London (1)
Australia (2) · Benin (2) · Brazil (2) · Canada (2) · China (2) · Ghana (2) · Guinea (2) · Indonesia (2) · South Africa (2) · Spain (2) · France (1) · Mongolia (1) · Saudi Arabia (1) · South Korea (1) · Taiwan (1)
Andrey S Borisov, MD, MPH (1) · Davaasambuu Ganmaa, MD PhD (1) · Dick Menzies, MD (1) · Dick Menzies, MD, MSc (1) · Jann-Yuan Wang, MD, PhD (1) · Keren Middelkoop, MPH, PhD (1) · Robert Belknap, MD (1) · Shuihua Lu, bachelor (1)
PMID 31866327, PMID 32539440, PMID 32785709, PMID 36949623, PMID 20627913, PMID 25404412, PMID 29114781, PMID 29393655, PMID 30067928, PMID 30067931, PMID 32706534, PMID 36441522, PMID 36815322, PMID 38048799, PMID 38211601, PMID 38599800, PMID 38996972, PMID 39345833